The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Pathway based network medicine identifies novel natural products for Alzheimer's disease Alzheimer's Research & Therapy Springer Nature Link Growth factors and their peptide mimetics for treatment of traumatic brain injury ScienceDirect Brain peptides in Alzheimer's disease pathophysiology and therapeutic advances Cell and Tissue Research Springer Nature Link